BR0205970A - Modulação favorável da qualidade de vida relacionada à saúde e a qualidade ajustada ao tempo de progressão da doença relacionada à saúde em pacientes com c ncer de próstata - Google Patents
Modulação favorável da qualidade de vida relacionada à saúde e a qualidade ajustada ao tempo de progressão da doença relacionada à saúde em pacientes com c ncer de próstataInfo
- Publication number
- BR0205970A BR0205970A BR0205970-3A BR0205970A BR0205970A BR 0205970 A BR0205970 A BR 0205970A BR 0205970 A BR0205970 A BR 0205970A BR 0205970 A BR0205970 A BR 0205970A
- Authority
- BR
- Brazil
- Prior art keywords
- health
- quality
- life
- time
- progression
- Prior art date
Links
- 230000002349 favourable effect Effects 0.000 title abstract 3
- 206010060862 Prostate cancer Diseases 0.000 title abstract 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 206010061818 Disease progression Diseases 0.000 abstract 2
- 230000005750 disease progression Effects 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/832,752 US20030022811A1 (en) | 2001-04-11 | 2001-04-11 | Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
| US11848602A | 2002-04-08 | 2002-04-08 | |
| PCT/US2002/011397 WO2002085351A1 (en) | 2001-04-11 | 2002-04-11 | Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0205970A true BR0205970A (pt) | 2003-09-30 |
Family
ID=26816420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0205970-3A BR0205970A (pt) | 2001-04-11 | 2002-04-11 | Modulação favorável da qualidade de vida relacionada à saúde e a qualidade ajustada ao tempo de progressão da doença relacionada à saúde em pacientes com c ncer de próstata |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1379238A1 (enExample) |
| JP (1) | JP2005503339A (enExample) |
| CN (1) | CN1514727A (enExample) |
| AR (1) | AR033465A1 (enExample) |
| BR (1) | BR0205970A (enExample) |
| CA (1) | CA2442591A1 (enExample) |
| IL (1) | IL158071A0 (enExample) |
| MX (1) | MXPA03009277A (enExample) |
| PE (1) | PE20021032A1 (enExample) |
| WO (1) | WO2002085351A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0219660D0 (en) | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
| WO2004100991A1 (en) * | 2003-05-15 | 2004-11-25 | Universite Catholique De Louvain | Use of endothelin-1 antagonists for improving cancer therapy |
| GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
| WO2007133796A2 (en) * | 2006-05-15 | 2007-11-22 | Encysive Pharmaceuticals, Inc. | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist |
| CA2904447C (en) | 2007-08-22 | 2017-01-03 | Abbvie Deutschland Gmbh & Co Kg | Therapy for complications of diabetes |
| WO2023011596A1 (zh) * | 2021-08-05 | 2023-02-09 | 中国药科大学 | 酰胺类化合物及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200101234T2 (tr) * | 1997-08-04 | 2002-06-21 | Abbott Laboratories | Endotelin antagonistleri. |
-
2002
- 2002-04-11 EP EP02726727A patent/EP1379238A1/en not_active Ceased
- 2002-04-11 CN CNA028116720A patent/CN1514727A/zh active Pending
- 2002-04-11 JP JP2002582924A patent/JP2005503339A/ja active Pending
- 2002-04-11 AR ARP020101335A patent/AR033465A1/es not_active Application Discontinuation
- 2002-04-11 WO PCT/US2002/011397 patent/WO2002085351A1/en not_active Ceased
- 2002-04-11 CA CA002442591A patent/CA2442591A1/en not_active Abandoned
- 2002-04-11 PE PE2002000305A patent/PE20021032A1/es not_active Application Discontinuation
- 2002-04-11 MX MXPA03009277A patent/MXPA03009277A/es unknown
- 2002-04-11 IL IL15807102A patent/IL158071A0/xx unknown
- 2002-04-11 BR BR0205970-3A patent/BR0205970A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2442591A1 (en) | 2002-10-31 |
| EP1379238A1 (en) | 2004-01-14 |
| CN1514727A (zh) | 2004-07-21 |
| JP2005503339A (ja) | 2005-02-03 |
| AR033465A1 (es) | 2003-12-17 |
| WO2002085351A1 (en) | 2002-10-31 |
| MXPA03009277A (es) | 2004-03-10 |
| PE20021032A1 (es) | 2002-11-12 |
| IL158071A0 (en) | 2004-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1992695T3 (da) | Lectin-transmembran-antigen af type C udtrykt i human prostatacancer og avendelser deraf | |
| ATE515235T1 (de) | Instrumentenaufbau zur verwendung in der wirbelsäulenchirurgie | |
| CY1106285T1 (el) | Χρηση αναστολεων της τυροσινης κινασης του egfr για τη θepαπεια του καρκινου του μαστου | |
| DE60320003D1 (de) | Führungsblock zur verwendung in der chirurgie | |
| AU2001228767A1 (en) | Forceps useful for intrabody guiding and/or positioning of medical instrument | |
| BRPI0411200A (pt) | método de tratamento de cáncer, métodos de tratamento de paciente humano, artigo industrializado e kit de tratamento de cáncer | |
| ATE400813T1 (de) | Tumormarker für frühes krebsstadium | |
| DE69920178D1 (de) | Super-elastische gebogene hohlnadel zur medizinischen verwendung | |
| ATE342702T1 (de) | Zwischenwirbelfusionsimplantat sowie instrument zur platzierung und distraktion des implantates | |
| EP0772456A4 (en) | DIAGNOSIS AND TREATMENT OF CELL PROLIFERATIVE DISEASES WITH THE PARTICIPATION OF CLONAL MACROPHAGES | |
| CY1110029T1 (el) | Γονιδιο που εκφραζεται στον καρκινο του προστατη | |
| AU2002239491A1 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
| BR0205970A (pt) | Modulação favorável da qualidade de vida relacionada à saúde e a qualidade ajustada ao tempo de progressão da doença relacionada à saúde em pacientes com c ncer de próstata | |
| PT981348E (pt) | Utilizacao de levobupivacaina em cirurgia pediatrica | |
| CY1115407T1 (el) | Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων | |
| GB0305575D0 (en) | Novel compounds | |
| AU2002350950A1 (en) | Compounds for imaging alzheimer's disease | |
| EP1575993A4 (en) | METHOD FOR TREATING PATIENTS AND IDENTIFYING THERAPEUTICS | |
| DE60224299D1 (de) | Kombinationsmedikationen mit einem selektiven cyclooxygenase-2-inhibitor | |
| IT1278858B1 (it) | Strumentario per il trattamento di fratture articolari della caviglia | |
| PL367707A1 (en) | Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol | |
| PT585801E (pt) | Proteina tipo caderina relacionada com osso e processo para a sua producao | |
| AU2003250912A1 (en) | Agents and methods for diagnosis and therapy of cancer and cancer risk assessment | |
| BRPI0408322A (pt) | uso de um fibrato e orlistat para o tratamento da obesidade | |
| ITBO20030261A1 (it) | Unita'di irraggiamento luminoso per diagnosi e cura di problemi cutanei. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 9A ANUIDADE(S) |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |